About TransMedics Group, Inc. Common Stock (TMDX)

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage.

TMDX trading today

TMDX has traded between $92.50 and $97.56 in the current session, a range of $5.06. The latest price of $93.57 sits in the middle of that range (21% of the way from low to high). It opened at $94.00, a gap up of 0.22% from the prior close of $93.79. The volume-weighted average price is $95.51, and the stock is trading below it. Traders often use VWAP as a gauge of whether buyers or sellers have had the better average entry today.

Where TMDX holders stand

StockMarketLoop's Market Position model estimates how the shares traded between 2026-08-12 and 2026-11-10 were bought. Its estimate of the average cost basis is $78.49; at $93.57 the stock trades 19.2% above that level. About 96.2% of those shares are estimated to be held at a profit at the current price. A high figure means most recent buyers are in the green, which can mean fewer trapped holders overhead, and also more people with gains who might sell. The densest nearby clusters of cost basis sit around $70.40 (support) and $93.45 (resistance). Roughly 70% of the estimated cost basis lies between $69.03 and $88.23, and 90% between $66.84 and $92.62.

This is a model estimate built from price and volume history, not a record of actual positions.

How to read this page

Quote figures come from StockMarketLoop's market data feed and may be delayed; the timestamp in the summary above shows when they were observed. Company details come from public reference data. The cost-basis section is a statistical model, not a forecast. Nothing here is investment advice; see our financial disclaimer and editorial policy.